Skip to main content

Table 3 Additional physiological parameters required for the MTB tissue models applied to brain and heart.

From: Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination

Tissue

Vbla (mL/100 g tissue)

Stb (dm2/g tissue)

FP-gp, tc (-)

ClP-gp, td (L/min)

PSAte (L/min)

Clout, OTf (L/min)

Brain

2g

2h

0.42

3.71 × 10-4

3.56 × 10-5

2.8 × 10-4

Heart

20i

11.8j

0.26

2.61 × 10-4

1.2 × 10-3

---

  1. a Volume of blood in equilibrium with tissue
  2. b Exchange surface area
  3. c Relative fraction of mdr1a/1b mRNA expression in mice tissues compared to that in intestine, calculated from published data[6]. We calculated the ratio of multidrug resistance PCR product to that of β-actin in each organ and we related these ratios to that obtained in mice intestine tissue.
  4. d P-gp efflux clearance
  5. e Permeability-Surface area product
  6. f Parameter fitted to in vivo tissue concentrations
  7. g Intermediate value of published values: 1.6 uL/g brain [29]; 0.94 ug/g [30]; 3 ug/g [31]
  8. h Intermediate value of those published (1.50–2.40 dm2/g tissue) [32, 33]
  9. i Rat value [34]. Same ratio was found in guinea pigs [35]
  10. j Human data applied to mice: Surface area of cardiac capillaries [36]